William Ferrell on Muck Rack

William Ferrell

United States
As seen in: BMJ Oncology, Nature, BMJ Open, JAMA (The Journal of the American Medical Association), Mary Ann Liebert, Inc., WTVD-TV (Durham, NC), WARC, Dialnet - Universidad de La Rioja, The Journal of the American Dental Association
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with William

Contact William, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Human-AI teaming to improve accuracy and efficiency of eligibility criteria prescreening for oncology trials: a randomized evaluation trial using retrospective electronic health records | Nature Communications

|
By Ravi Parikh Verified, William Ferrell
| Nature Verified
Abstract Few adult patients with cancer enroll in oncology clinical trials. A rate-limiting step to trial enrollment is prescreening, involving clinical research staff manually abstracting unstructured health records to identify patients who meet eligibility criteria. Prescreening is time-consuming, labor-intensive, and prone to human error, resulting in under-identification of eligible patients.
Open in Who Shared Issue with article?

Compensating for inspection errors in attribute inspection

|
By Anand Gramopadhye, William Ferrell, Venu Gopal Pajjuri, Delbert Kimbler
| Dialnet - Universidad de La Rioja
Ayuda Buscar en la ayuda Buscar en la ayuda
Open in Who Shared View Duplicates (668) Issue with article?

Specificity of Food and Drug Administration postmarketing requirements and associations with timely submissions and regulatory decisions for oncology accelerated approvals, 2011-2023: a cross-sectional analysis | BMJ Oncology

|
By Martin Kurian, William Ferrell, Ernesto Pérez Verified, Rebecca Hubbard
| BMJ Oncology Verified
For drug indications receiving accelerated approval (AA), the Food and Drug Administration (FDA) imposes postmarketing requirements (PMRs). The FDA and sponsors negotiate parameters for PMR studies, including design features and submission timelines, which are formalised as PMR statements. PMR studies have been criticised for delay and lack of rigour; the contribution of PMR statements to this problem has not been well studied.
Open in Who Shared Issue with article?
See all 14 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified